# Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

> **NCT04811703** · PHASE1 · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 15 (estimated)

## Conditions studied

- Metastatic Ovarian Carcinoma
- Peritoneal Carcinomatosis
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- Stage III Fallopian Tube Cancer
- Stage IV Fallopian Tube Cancer
- Metastatic Malignant Neoplasm in the Peritoneum

## Interventions

- **DRUG:** Combined PIPAC / IV chemotherapy treatment

## Key facts

- **NCT ID:** NCT04811703
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-30
- **Primary completion:** 2026-06
- **Final completion:** 2027-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811703, "Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04811703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*